Publications by authors named "Erica Lessem"

Claim this Profile
S
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis.
Michael Reid, Yvan Jean Patrick Agbassi, Nimalan Arinaminpathy, Alyssa Bercasio, Anurag Bhargava, Erica Lessem

Lancet· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public investments in the clinical development of bedaquiline.
Dzintars Gotham, Lindsay McKenna, Mike Frick, Erica Lessem

PLoS One· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers.
Diane N Singhroy, Emily MacLean, Mikashmi Kohli, Erica Lessem, David Branigan

Gates Open Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial.
Susan E Dorman, Payam Nahid, Ekaterina V Kurbatova, Stefan V Goldberg, Lorna Bozeman, Erica Lessem

Contemp Clin Trials· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Key features to consider in revising the Model List of Essential In Vitro Diagnostics: a TB perspective.
Khairunisa Suleiman, Kathleen England, Erica Lessem, Lindsay McKenna

Int J Tuberc Lung Dis· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommending prolonged bedaquiline use for the treatment of highly resistant strains of tuberculosis.
Jennifer Furin, Erica Lessem, Vivian Cox

Eur Respir J· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bedaquiline or delamanid for rifampin-resistant tuberculosis?
Erica Lessem, Vivian Cox, Jennifer Furin

Lancet Respir Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.
Keertan Dheda, Tawanda Gumbo, Gary Maartens, Kelly E Dooley, Ruth McNerney, Erica Lessem

Lancet Respir Med· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ensuring availability of the best tuberculosis treatment options in the Philippines.
Erica Lessem, Mike Frick

Int J Tuberc Lung Dis· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Falling Short of the Rights to Health and Scientific Progress: Inadequate TB Drug Research and Access.
Mike Frick, Ian Henry, Erica Lessem

Health Hum Rights· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis.
Jennifer Furin, Grania Brigden, Erica Lessem, Michael Rich, Laura Vaughan

Emerg Infect Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compassionate and optimum use of new tuberculosis drugs.
Caitlin Reed, Leona Mason, Helen Cox, Barbara Seaworth, Erica Lessem

Lancet Infect Dis· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards early inclusion of children in tuberculosis drugs trials: a consensus statement.
Sharon Nachman, Amina Ahmed, Farhana Amanullah, Mercedes C Becerra, Radu Botgros, Erica Lessem

Lancet Infect Dis· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Informed use of bedaquiline for tuberculosis.
Erica M Lessem, John Bernardo, Caitlin Reed, Donna H Wegener

Lancet· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to new medications for the treatment of drug-resistant tuberculosis: patient, provider and community perspectives.
Erica Lessem, Helen Cox, Colleen Daniels, Jennifer Furin, Lindsay McKenna

Int J Infect Dis· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real engagement with communities.
Laia Ruiz Mingote, Wim Vandevelde, Blessina Kumar, Erica Lessem

Lancet Respir Med· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving role of advocacy in tuberculosis.
Andrea DeLuca, Erica Lessem, Donna Wegener, Laia Ruiz Mingote, Mike Frick

Lancet Respir Med· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Russia: Drug-resistant TB can be contained.
Erica Lessem, Salmaan Keshavjee

Nature· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engaging communities in tuberculosis research.
Renaud F Boulanger, Stephanie Seidel, Erica Lessem, Lee Pyne-Mercier, Sharon D Williams

Lancet Infect Dis· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis